SLC5A2 and Fabry disease: This retrospective case-control study aimed to explore the effects of SGLT2 inhibitors on estimated glomerular filtration rate (eGFR) slopes, the urinary albumin-to-creatinine ratio (UACR), and plasma B-type natriuretic peptide (BNP) levels in patients with FD using data derived from our institutional database.